Prana Biotechnology: Revised Table in 2012 Annual Report
(firmenpresse) - MELBOURNE, AUSTRALIA -- (Marketwire) -- 10/08/12 -- (NASDAQ: PRAN) (ASX: PBT) today announced that it has identified the below correction to a table lodged in the Company's Annual Report on 28 September 2012. The table appears on page 45 on the notes to the financial statements in the annual report. The correction related to 2012 "Short-term employee benefits" and "Post-employment benefits." The revised table is attached.
Finalisation of printing of the annual report is now underway and Prana looks forward to the report being dispatched to all shareholders who have nominated to receive a hard copy of the report in the near future. The revised report will also be released on the ASX at that same time.
Prana Biotechnology was established to commercialize research into age-related neurodegenerative disorders. The Company was incorporated in 1997 and listed on the Australian Securities Exchange in March 2000 and listed on NASDAQ in September 2002. Researchers at prominent international institutions including The University of Melbourne, The Mental Health Research Institute (Melbourne) and Massachusetts General Hospital, a teaching hospital of Harvard Medical School, contributed to the discovery of Prana's technology.
For further information please visit the Company's web site at .
Image Available:
Contacts:
Australia
Prana Biotechnology
+61 3 9349 4906
US
Leslie Wolf-Creutzfeldt
T: 646-284-9472
E:
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 08.10.2012 - 07:01 Uhr
Sprache: Deutsch
News-ID 1157930
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
MELBOURNE, AUSTRALIA
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 170 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Prana Biotechnology: Revised Table in 2012 Annual Report
"
steht unter der journalistisch-redaktionellen Verantwortung von
Prana Biotechnology (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
